Author

Simona Coco

h-index 2 View on Semantic Scholar

We have 3 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Reprogramming the tumor microenvironment in mesothelioma: from immune suppression to therapeutic opportunity

Pleural mesothelioma (PM) is a rare and aggressive cancer with limited treatment options and poor prognosis. Unlike other thoracic cancers responding well to immunotherapy, PM typically lacks key predictive biomarkers such as Programmed Death-Ligand 1 (PD-L1) tumor expression. Nonetheless, immune checkpoint inhibitors...

L. Cerbone, Alessia Garau, Andrea Balossino et al. · Frontiers in Immunology · 0 citations

Open access Sep 2026

Host-derived immunometabolic biomarkers identify prognostic profiles under immunotherapy in advanced NSCLC: the SARC-LUNG study

Immune checkpoint inhibitors (ICIs) improve outcomes in advanced non-small cell lung cancer (NSCLC), but predictive biomarkers remain limited. Host-derived immunometabolic factors may modulate response to ICIs. In the prospective SARC-LUNG study, 40 patients with advanced NSCLC treated with first-line ICIs...

A. De Giglio, Maria Conte, Simona Coco et al. · Cancer Immunology and Immuno... · 0 citations

Review Open access Jul 2026

Recent advances in EGFR-targeted therapies for non-small cell lung cancer

This review discusses recent advances in EGFR-targeted therapies within the molecular landscape of classical and uncommon EGFR mutations, focusing on frontline intensification strategies in metastatic disease—specifically TKI combinations with chemotherapy or bispecific antibodies or bispecific antibodies—and emerging...

L. Lucente, Lucrezia Barcellini, Beatrice Ramella Pollone et al. · Expert Opinion on Pharmacoth... · 0 citations